Newark Beth Israel Medical Center recently announced it is now the first and only hospital in New Jersey offering SuperSaturated Oxygen Therapy to treat heart attack patients.
SuperSaturated Oxygen Therapy is indicated for use in patients who suffer a heart attack caused by a complete blockage of the left-anterior descending coronary artery, which supplies a large portion of blood to the heart muscle.
The first procedure was performed on Nov. 7 by Dr. Khalil Kaid, director of interventional cardiology at Newark Beth Israel Medical Center.
Cardiologists deliver high levels of dissolved oxygen (7-10 times normal level) directly into the damaged heart muscle to greatly improve blood flow and reduce irreversible damage. The procedure is performed within six hours of the initial heart attack and within minutes of successfully opening the artery through angioplasty and stenting.
“We are excited to offer our patients a new minimally invasive interventional cardiac therapy. Now our cardiologists can use SuperSaturated Oxygen Therapy to target the heart muscle with even more precision and prevent severe damage which often leads to heart failure,” Kaid said.
According to the American Heart Association, up to 30% of heart attack patients develop heart failure within one year, and a diagnosis of heart failure carries a more than 50% mortality rate at five years. Studies show that the use of SSO2 has been associated with improved one-year clinical outcomes, including lower rates of death and new on-set heart failure or heart failure hospitalizations.
“SuperSaturated Oxygen Therapy is one of many cutting-edge cardiac therapies available at Newark Beth Israel Medical Center. Patients come to us from across the state and region to receive advanced cardiac care, and our team is committed to delivering the most innovative medical, surgical and interventional cardiac procedures available,” Dr. Sergio Waxman, chief, Division of Cardiology at Newark Beth Israel Medical Center, said.